Despite the hype about weight loss drugs known as GLP-1s, serious questions have remained about their efficacy when patients wean off the drugs. But Omada Health, a virtual chronic care provider, is ...

SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth companies quickly added programs to prescribe anti-obesity drugs. Omada Health ...

“The promise of GLP-1s is clear: significant weight loss that unlocks broader health benefits. But that promise requires persistence through real-world challenges. As the GLP-1 landscape evolves with ...